Witnessing the stock’s movement on the chart, on January 12, 2022, Compugen Ltd. (NASDAQ: CGEN) had a quiet start as it plunged -6.56% to $3.99. During the day, the stock rose to $4.34 and sunk to $3.98 before settling in for the price of $4.27 at the close. Taking a more long-term approach, CGEN posted a 52-week range of $3.68-$14.22.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -26.40%. Meanwhile, its Annual Earning per share during the time was 1.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 13.10%. This publicly-traded company’s shares outstanding now amounts to $83.98 million, simultaneously with a float of $79.04 million. The organization now has a market capitalization sitting at $334.84 million. At the time of writing, stock’s 50-day Moving Average stood at $4.82, while the 200-day Moving Average is $6.64.
If we measure the efficiency of the company that is accounted for 68 employees. It has generated 29,412 per worker during the last fiscal year. Meanwhile, its income per employee was -436,735. The stock had 1.59 Receivables turnover and 0.02 Total Asset turnover. For the Profitability, stocks gross margin was +61.25, operating margin was -1574.80 and Pretax Margin of -1484.90.
Compugen Ltd. (CGEN) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Compugen Ltd.’s current insider ownership accounts for 12.00%, in contrast to 43.40% institutional ownership.
Compugen Ltd. (CGEN) Earnings and Revenue Records
As on 9/29/2021, Multinational firm has announced its last quarter scores, in which it reported -$0.07 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.12) by $0.05. This company achieved a net margin of -1484.90 while generating a return on equity of -37.57. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
Compugen Ltd.’s EPS increase for this current 12-month fiscal period is 13.10% and is forecasted to reach -0.70 in the upcoming year.
Compugen Ltd. (NASDAQ: CGEN) Trading Performance Indicators
Let’s observe the current performance indicators for Compugen Ltd. (CGEN). It’s Quick Ratio in the last reported quarter now stands at 7.40. The Stock has managed to achieve an average true range (ATR) of 0.30. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 41.86.
In the same vein, CGEN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.41, a figure that is expected to reach -0.10 in the next quarter, and analysts are predicting that it will be -0.70 at the market close of one year from today.
Technical Analysis of Compugen Ltd. (CGEN)
Going through the that latest performance of [Compugen Ltd., CGEN]. Its last 5-days volume of 0.84 million was inferior to the volume of 0.86 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 30.92% While, its Average True Range was 0.29.
Raw Stochastic average of Compugen Ltd. (CGEN) in the period of the previous 100 days is set at 8.16%, which indicates a major rise in contrast to 5.52% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 64.66% that was lower than 70.86% volatility it exhibited in the past 100-days period.